Theranos founder Holmes stays out of prison with appeal

Theranos founder Holmes stays out of prison with appeal

Former Theranos CEO Elizabeth Holmes was to begin serving prison time on April 27 after the judge who presided over her trial denied her bid to remain free
Former Theranos CEO Elizabeth Holmes was to begin serving prison time on April 27 after the judge who presided over her trial denied her bid to remain free. Photo: JUSTIN SULLIVAN / GETTY IMAGES NORTH AMERICA/Getty Images via AFP
Source: AFP

Fallen US biotech star Elizabeth Holmes will stay out of prison for now after her lawyers lodged a last-minute appeal to avoid starting her 11 year sentence.

Holmes was set to begin her sentence on April 27 after being found guilty in January 2022 for defrauding investors with her Silicon Valley start-up Theranos.

Earlier this month, Holmes was refused a request to remain free pending her appeal.

Her lawyers on Tuesday informed a US judge that they were appealing that decision, meaning she could remain out of prison for the time it took to decide that request.

Holmes was found responsible of duping investors that she had developed a revolutionary medical device.

The 39-year-old became a star of Silicon Valley when she said her start-up was perfecting an easy-to-use test kit that could carry out a wide range of medical diagnostics with just a few drops of blood.

Read also

Tears, lamentation as missing APGA governorship aspirant found dead

PAY ATTENTION: Сheck out news that is picked exactly for YOU ➡️ find the “Recommended for you” block on the home page and enjoy!

But her company flamed out after a Wall Street Journal investigation into the validity of the tests.

Holmes had a child shortly before her trial and has had a second since her conviction.

A top aide and ex-boyfriend to the Theranos chief was convicted at a separate trial and is also slated to serve time in prison.

Ramesh "Sunny" Balwani was sentenced to nearly 13 years in prison for his role in what prosecutors argued was a massive fraud perpetuated on Theranos investors and patients.

Source: AFP

Authors:
AFP avatar

AFP AFP text, photo, graphic, audio or video material shall not be published, broadcast, rewritten for broadcast or publication or redistributed directly or indirectly in any medium. AFP news material may not be stored in whole or in part in a computer or otherwise except for personal and non-commercial use. AFP will not be held liable for any delays, inaccuracies, errors or omissions in any AFP news material or in transmission or delivery of all or any part thereof or for any damages whatsoever. As a newswire service, AFP does not obtain releases from subjects, individuals, groups or entities contained in its photographs, videos, graphics or quoted in its texts. Further, no clearance is obtained from the owners of any trademarks or copyrighted materials whose marks and materials are included in AFP material. Therefore you will be solely responsible for obtaining any and all necessary releases from whatever individuals and/or entities necessary for any uses of AFP material.